2014
Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer.
Nadeem O, Mega A, Keller E, Renzulli J, Quesenberry P, Chatterjee D. Extracellular vesicle-mediated reversal of taxane resistance and the malignant phenotype in prostate cancer. Journal Of Clinical Oncology 2014, 32: e16028-e16028. DOI: 10.1200/jco.2014.32.15_suppl.e16028.Peer-Reviewed Original Research
2013
766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIAL
Maddox M, Layton J, Taber A, Mega A, Renzulli J. 766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIAL. Journal Of Urology 2013, 189: e314-e315. DOI: 10.1016/j.juro.2013.02.330.Peer-Reviewed Original Research1248 PROSTATE MRI TO EVALUATE EXTRA-CAPSULAR EXTENSION AND SEMINAL VESICLE INVASION IN PROSTATE CANCER IN A COMMUNITY SETTING
Bishop K, Layton J, Furman M, Maddox M, Grand D, Renzulli J, Mega A. 1248 PROSTATE MRI TO EVALUATE EXTRA-CAPSULAR EXTENSION AND SEMINAL VESICLE INVASION IN PROSTATE CANCER IN A COMMUNITY SETTING. Journal Of Urology 2013, 189: e510-e511. DOI: 10.1016/j.juro.2013.02.2602.Peer-Reviewed Original Research